The recently published study by the team of Dr. J. Verhoeven from UMC Rotterdam uses the panel of DigitalTRACE™ Assays to investigate the diagnostic value of donor-derived cell-free DNA (dd-cfDNA) for the detection of acute kidney transplant rejection.

We are proud to announce that we have recently developed six new HLA assays, targeting allele subgroup A and C from the Class I HLA group. The new assays will be a welcome addition to our increasingly popular HLA TRACE™ panel, extending the number of HLA assays available to our customers to 28.

To present our innovative products for diagnostics and to meet our current and new customers, collaborators and scientific experts, JETA Molecular will be attending the ASHI 47th Annual Meeting in Orlando, September 23 to October 1, and the SFHI 2021 meeting in Lyon, October 7-8. We look forward to meet everyone in person after a long period of virtual-only events!